| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.79B | 168.19B | 160.65B | 123.20B | 107.78B | 92.64B |
| Gross Profit | 49.03B | 53.91B | 50.89B | 38.94B | 32.70B | 24.98B |
| EBITDA | 13.96B | 16.88B | 16.06B | 7.93B | 6.19B | 2.14B |
| Net Income | 10.54B | 12.60B | 17.92B | 6.44B | 3.73B | -2.90B |
Balance Sheet | ||||||
| Total Assets | 190.41B | 199.61B | 253.17B | 205.10B | 166.99B | 134.30B |
| Cash, Cash Equivalents and Short-Term Investments | 57.79B | 54.39B | 51.67B | 50.85B | 51.71B | 42.42B |
| Total Debt | 10.58B | 10.88B | 11.80B | 14.39B | 14.45B | 14.51B |
| Total Liabilities | 74.58B | 82.43B | 141.46B | 115.98B | 83.47B | 52.14B |
| Stockholders Equity | 115.82B | 117.17B | 111.70B | 89.12B | 83.52B | 82.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.62B | 6.20B | -1.35B | 10.05B | -1.35B |
| Operating Cash Flow | 0.00 | 8.33B | 9.31B | 934.00M | 11.30B | 192.00M |
| Investing Cash Flow | 0.00 | 910.00M | -3.81B | -563.00M | -1.26B | -1.54B |
| Financing Cash Flow | 0.00 | -6.53B | -6.70B | -2.28B | -2.11B | -4.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥87.03B | 136.93 | 5.02% | 3.23% | -10.00% | -51.92% | |
78 Outperform | ¥115.61B | 12.40 | ― | 3.24% | 18.70% | 33.93% | |
74 Outperform | ¥81.04B | 14.21 | 9.39% | 1.68% | 9.27% | 69.52% | |
74 Outperform | ¥60.33B | 24.26 | ― | 2.54% | 2.00% | 39.80% | |
69 Neutral | ¥67.02B | 10.78 | 7.00% | 3.02% | 15.78% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
42 Neutral | ¥16.93B | -8.05 | ― | 4.21% | 2.79% | -281.15% |